James Niedel

Investor type:
Locations:

Social media:

Available after registration.

Past investments

  • iRhythm Technologies
  • Braeburn
  • Direct Flow Medical
  • Edgewise Therapeutics
  • Karyopharm Therapeutics
  • CRISPR Therapeutics
  • Kit Check
  • Advanced Cell Diagnostics
  • Wave Life Sciences
  • IRLAB Therapeutics
  • Arvinas
  • Versartis
  • Edge Therapeutics
  • Alector
  • UNUM Therapeutics
  • Aptinyx
  • Awarepoint
  • Harpoon Therapeutics
  • CardioKinetix
  • Intarcia Therapeutics
  • Cogent Biosciences
  • Relypsa
  • Neurana Pharmaceuticals
  • Treato
  • Rallybio
  • ReViral
  • Afferent Pharmaceuticals
  • Karus Therapeutics
  • Principia Biopharma
  • Pearl Therapeutics
  • ReShape Lifesciences
  • Catalyst Pharmaceuticals Partners
  • GluMetrics
  • Kalidex Pharmaceuticals
  • Oxford Immunotec
  • IlluminOss Medical
  • Aviir
  • Kyruus
  • Renovacor
  • Glympse Bio
  • CuraSen Therapeutics
  • Access Closure
  • BioRelix
  • DiCE Molecules
  • Passage Bio
  • Qlaris Bio
  • Technology Will Save Us
  • Neuronetics
  • AiCure
  • True North Therapeutics
  • TigerConnect
  • Dimension Therapeutics
  • Presidio Pharmaceuticals
  • Bellus Health
  • BrightInsight
  • Truveris
  • Iterum Therapeutics
  • ObsEva
  • Deciphera Pharmaceuticals
  • QPID Health